Miles Congreve
227 works · 25,991 citations · h-index 44
Top works
- Accurate structure prediction of biomolecular interactions with AlphaFold 3
- A ‘Rule of Three’ for fragment-based lead discovery?
- Fragment-based lead discovery
- Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B
- Recent Developments in Fragment-Based Drug Discovery
- Fragment-based lead discovery: leads by design
- Structure of the Adenosine A2A Receptor in Complex with ZM241385 and the Xanthines XAC and Caffeine
- Keynote review: Structural biology and drug discovery
- Fragment-Based Drug Discovery Applied to Hsp90. Discovery of Two Lead Series with High Ligand Efficiency
- Identification of Novel p38α MAP Kinase Inhibitors Using Fragment-Based Lead Generation
- Application of Fragment-Based Lead Generation to the Discovery of Novel, Cyclic Amidine β-Secretase Inhibitors with Nanomolar Potency, Cellular Activity, and High Ligand Efficiency
- Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design
- Discovery of (2,4-Dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a Novel Inhibitor of the Molecular Chaperone Hsp90 by Fragment Based Drug Design
- Application of Fragment Screening by X-ray Crystallography to the Discovery of Aminopyridines as Inhibitors of β-Secretase
- Progress in Structure Based Drug Design for G Protein-Coupled Receptors
- Application of Fragment Screening by X-ray Crystallography to β-Secretase
- Impact of GPCR Structures on Drug Discovery
- Selective Cleavage of Benzyl Ethers
- Addendum: Accurate structure prediction of biomolecular interactions with AlphaFold 3
- Tetrazole NK1 receptor antagonists: The identification of an exceptionally potent orally active antiemetic compound